Jun 25, 2014
Court Report - June 2014 #4
Cephalon Inc. v. Actavis Laboratories FL Inc. et al. 1:14-cv-00776; filed June 19, 2014 in the District Court of Delaware Infringement of U.S. Patent Nos.
How I Survived The Topsy-Turvy Pharmaceutical Industry
With Pfizer's attempted takeover of AstraZeneca, Merck & Co.' s continued downsizing, and the recent acquisition of Cephalon Inc., the Philadelphia region's pharmaceutical sector is going through some big changes.
Aratana Therapeutics Adds Robert P. Roche, Jr. to Board of Directors
Aratana Therapeutics, Inc. , a pet therapeutics company focused on the licensing, development and commercialization of innovative biopharmaceutical products for cats, dogs and other companion animals, today announced the appointment of former Cephalon, Inc., executive Robert P. Roche, Jr. to its Board of Directors.
Breckenridge Pharmaceutical, Inc. Announces Paragraph IV Anda...
Breckenridge Pharmaceutical, Inc. announced today that it has filed an ANDA with a Paragraph IV certification for bendamustine hydrochloride powder for IV , 25 mg/vial and 100 mg/vial, a generic version of Treanda by Cephalon, Inc. On May 27, 2014, Cephalon, Inc. filed a Paragraph IV lawsuit against Breckenridge and its development and ... (more)
Courthouse News Service
Teva Dodges Suit Over Marketing of Fentora
Cephalon and Teva Pharmaceuticals need not face racketeering claims over their off-label promotion of the addictive painkiller Fentora, a federal judge ruled.